drugset / Trial / NCT04464577
A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the effect of inhibitors, at steady state, on the drug levels, safety, and tolerability of BMS-986235 when taken by healthy participants. The inhibitors to be utilized in this study are fluconazole, bupropion, and itraconazole.
Timeline
- Start
- 2021-04-01
- Primary completion
- 2021-06-07
- Completion
- 2021-06-08
Outcome
Outcome not reported
Stopped (Business): “Business objectives have changed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986235 | Small molecule | — | — |
| Subject | Bupropion | Small molecule | — | — |
| Subject | Fluconazole | Small molecule | — | — |
| Subject | Itraconazole | Small molecule | — | — |
Indications
No indication recorded.